Liquid-Based Cytology
The SurePath™ LBC system uses a proprietary sample collection method and patented centrifugal sedimentation technology — the third-generation cytology testing method. It delivers automated, standardised, high-throughput slide preparation with industry-leading specimen adequacy rates and the highest FDA-certified cancer precursor detection rate compared to conventional Pap smears.
Vaginal Infection Testing
The Affirm™ VPIII is the industry's first fully automated system using DNA probe technology to simultaneously detect the three most common vaginal pathogens — Bacterial Vaginosis (BV), Vulvovaginal Candidiasis (VVC) and Trichomonas Vaginalis (TV) — from a single sample. It has become the standard method for vaginal infection testing recommended by the US Centers for Disease Control and Prevention (CDC).
HPV Testing
The Viper LT™ is a benchtop molecular platform that automates DNA extraction, RT-PCR amplification, detection and result reporting — minimising manual intervention. Paired with the Onclarity™ HPV Assay, it delivers genotyping results for 14 high-risk HPV types, with individual identification of 6 types, from the same SurePath™ vial used for liquid-based cytology — one sample, two tests.
Hong Kong Origins Investment Limited — Professional cross-border trade solutions for medical devices, specialising in cervical cancer screening, women's health diagnostics and IVD products.
Copyright © 2026 Hong Kong Origins Investment Limited. All rights reserved. Privacy Policy